Vaccines and Global Health: The Week in Review 25 Jan 2014

Vaccines and Global Health: The Week in Review is a weekly digest — summarizing news, events, announcements, peer-reviewed articles and research in the global vaccine ethics and policy space. Content is aggregated from key governmental, NGO, international organization and industry sources, key peer-reviewed journals, and other media channels. This summary proceeds from the broad base of themes and issues monitored by the Center for Vaccine Ethics & Policy in its work: it is not intended to be exhaustive in its coverage. You are viewing the blog version of our weekly digest, typically comprised of between 30 and 40 posts below all dated “29 June 2013″
.
Email Summary: Vaccines and Global health : The Week in Review is published as a single email summary, scheduled for release each Saturday eveningbefore midnight (EDT in the U.S.). If you would like to receive the email version, please send your request to david.r.curry@centerforvaccineethicsandpolicy.org.
.
pdf version: A pdf of the current issues is available here: Vaccines and Global Health_The Week in Review_25 Jan 2014
.
Twitter: Readers can also follow developments on twitter: @vaxethicspolicy.
.
Links: We endeavor to test each link as we incorporate it into any post, but recognize that some links may become “stale” as publications and websites reorganize content over time. We apologize in advance for any links that may not be operative. We believe the contextual information in a given post should allow retrieval, but please contact us as above for assistance if necessary.
.
Support: If you would like to join the growing list of individuals who support this service and its contribution to their roles in public health, clinical practice, government, IGOs/NGOs, research, industry and academia, please visit this page at The Wistar Institute, our co-founder and fiduciary. Thank you…
.
David R. Curry, MS
Executive Director
Center for Vaccine Ethics and Policy
a program of the
– Division of Medical Ethics, NYU Medical School
– The Wistar Institute Vaccine Center
– Children’s Hospital of Philadelphia Vaccine Education Center
Associate Faculty, Division of Medical Ethics, NYU Medical School

Measles outbreak threatens children’s lives in Guinea

UNICEF Watch
http://www.unicef.org/media/media_67204.html

Measles outbreak threatens children’s lives in Guinea
Excerpt
CONAKRY, 21 January 2014 – UNICEF and its partners have begun to organize a campaign to vaccinate over 1.6 million children to stop a measles outbreak in Guinea amid growing number of cases among children especially in the capital Conakry.

Since November last year, 37 cases have been confirmed in the capital–all children under 10 years old. Over the past few weeks, the number of cases of measles has been increasing sharply and led to the death of one child.

This recent spike has prompted the Ministry of Health and Public Hygiene of Guinea to officially declare an outbreak in the Conakry municipalities of Matam, Matoto, and Ratoma. The disease has also been reported in other parts of the country –namely the prefectures of Boké, Coyah, Dubreka, Kissidougou, and Mandiana.

“We are very concerned about this outbreak. Measles is highly contagious and extremely dangerous—especially for young, malnourished children. As we’ve already seen, it can be fatal. In a densely populated city like Conakry, disease spreads quickly,” said UNICEF Representative in Guinea Dr. Mohamed Ayoya.

The Government of Guinea, UNICEF, the World Health Organization (WHO) and Médecins Sans Frontières (MSF) are joining forces to set up coordinated mechanisms to contain the outbreak. For the initial response, UNICEF will provide vaccines, refrigerators, needles, and other medical supplies and logistical support to the Government for the vaccination of children in the Kaloum and Dixinn neighbourhoods of Conakry as well as in the affected areas outside the capital. MSF and WHO will support vaccination efforts in the outbreak-declared areas of Conakry –namely Matam, Matoto, and Ratoma.

The vaccination phase of the national campaign will begin in the coming weeks as soon as vaccines, supplies and funding to ensure a continuous rollout are available…

GPEI Update: Polio this week – As of 23 January 2014

Update: Polio this week – As of 23 January 2014
Global Polio Eradication Initiative
Full report: http://www.polioeradication.org/Dataandmonitoring/Poliothisweek.aspx

[Editor’s extract and bolded text]
:: The first four cases wild poliovirus cases type 1 (WPV1) have been reported for 2014. All cases were reported from North Waziristan, FATA, Pakistan. North Waziristan is the district with the largest number of children being paralyzed by poliovirus in the world. As long as polio still exists in reservoirs like North Waziristan, the world will always be at risk of outbreaks.
::The Gates Annual Letter for 2014 is now available, and polio eradication is shown as an example of what works in foreign aid.
:: The WHO/UNICEF Strategic Plan for Polio Outbreak Response in the Middle East [pdf] outlines the action plan for Syria and neighbouring countries in response to the circulation of wild poliovirus following importation. The objective is to stop the outbreak in Syria by the end of March 2014 and prevent any further international spread.
:: The WHO Executive Board (EB) is meeting in Geneva on 20-25 January. Ahead of the EB session, the Global Polio Eradication Initiative (GPEI) published the report: “Poliomyelitis: intensification of the global eradication initiative”. The full report is available in English and French here.

Pakistan
:: Four new WPV1 cases were reported in the past week, all from North Waziristan, FATA. The total number for WPV1 cases for Pakistan in 2014 is now 4. The total number of WPV1 cases for Pakistan in 2013 remains 91. The most recent WPV1 case had onset of paralysis on 5 January (from North Waziristan, FATA).

WHO: Humanitarian Health Action — Conflict and humanitarian crisis in Central African Republic

WHO: Humanitarian Health Action
Conflict and humanitarian crisis in Central African Republic
21 January 2014 — The insecurity in the country has limited and delayed delivery of health services. There has been disruptions of services provided by the mobile clinics, vaccination of children and services provided by hospitals on the axel Ouandago – Banforo – Bangui and Bandoro – Mbrès. A measles outbreak has been reported in Bria.
Latest situation Report: 21 January 2014 –
http://www.who.int/entity/hac/crises/caf/sitreps/car_who_sitrep_21january2014.pdf?ua=1

WHO: Global Alert and Response (GAR) – Disease Outbreak News [to 25 January 2014]

WHO: Global Alert and Response (GAR) – Disease Outbreak News
http://www.who.int/csr/don/2013_03_12/en/index.html

:: Human infection with avian influenza A(H7N9) virus – update 23 January 2014
On 22 January 2014, the National Health and Family Planning Commission of China notified WHO of 10 additional laboratory-confirmed cases of human infection with avian influenza A(H7N9) virus.

:: Human infection with avian influenza A(H7N9) virus – update 22 January 2014
On 20 January 2014, the National Health and Family Planning Commission of China notified WHO of five additional laboratory-confirmed cases of human infection with avian influenza A(H7N9) virus, including two deaths.

:: Human infection with avian influenza A(H7N9) virus – update 20 January 2014
The National Health and Family Planning Commission of China notified WHO of 16 additional laboratory-confirmed cases of human infection with avian influenza A(H7N9) virus.

:: Human infection with avian influenza A(H7N9) virus – update 20 January 2014
On 16 January 2014, the National Health and Family Planning Commission of China notified WHO of seven additional laboratory-confirmed cases of human infection with avian influenza A(H7N9) virus

IVI announces the resignation of Dr. Christian Loucq as IVI Director General

IVI announced the resignation of Dr. Christian Loucq as IVI Director General due to personal reasons effective February 28, 2014. The IVI Board of Trustees (BOT) has set up a selection committee that will manage the recruitment process and has also appointed Mr. John Morahan, currently Deputy Director General, Finance & Administration and Chief Financial Officer, to serve as Acting Director General during the transition period until the new Director General is in place. The announcement noted that under Dr. Loucq’s leadership, IVI’s “governance, systems and internal control, and management were strengthened.  As a result, organizational transparency to our major donors and stakeholders increased, and IVI’s financial situation and outlook improved significantly. Despite the challenges that occurred during his tenure, research programs continued and he brought to the forefront industrial partners from South Korea that promise to be important players for product development partnerships.  Due to Dr. Loucq’s strong leadership during a critical period of the organization, IVI is more stable and secure, and is well-positioned to embark on the next phase of its growth and evolution. The priorities of the new Director General will include scientific strategy and funding diversification.”

WHO: 134th WHO Executive Board session

WHO: Executive Board appoints Regional Directors
21 January 2014
The WHO Executive Board, currently holding its 134th session in Geneva, has appointed Dr Poonam Khetrapal Singh as the new WHO Regional Director for South-East Asia and reappointed Dr Shin Young-soo as the WHO Regional Director for the Western Pacific.
Full text:   | GENEVA – The http://www.who.int/mediacentre/news/notes/2014/eb-20140121/en/index.html

Speech: Report by the Director-General to the Executive Board at its 134th Session
WHO Director-General addresses the Executive Board
Dr Margaret Chan
Director-General of the World Health Organization
20 January 2014
Full text: http://www.who.int/dg/speeches/2014/executive-board-opening/en/index.html

WHO: 134th WHO Executive Board session
Date: 20–25 January 2014
Place: Geneva, Switzerland
Selected Documentation
Agenda
pdf, 281kb

Main documents
EB134/13 Global vaccine action plan

EB134/31 Access to essential medicines

EB134/33 Pandemic influenza preparedness: sharing of influenza viruses and access to vaccines and other benefits – Pandemic Influenza Preparedness Framework

EB134/34 Smallpox eradication: destruction of variola virus stocks

EB134/35 Poliomyelitis: intensification of the global eradication initiative

EB134/54 Contributing to social and economic development: sustainable action across sectors to improve health and health equity (follow up of the 8th Global Conference on Health Promotion)

Conference Papers
EB134/CONF./3 Biological medicines: access to medicines and ensuring safety, quality and efficacy

EB134/CONF./4 Rev.1 Global strategy and targets for tuberculosis prevention, care and control after 2015

EB134/CONF./8 Rev.1 Contributing to social and economic development: sustainable action across sectors to improve health and health equity (follow-up of the 8th Global Conference on Health Promotion)

EB134/CONF./9 Health intervention and technology assessment in support of universal health coverage

EB134/CONF./10 The role of the health system in addressing violence, in particular against women and girls

EB134/CONF./14 Access to essential medicines